The OnSite COVID-19 Ag Self Test is a single-use lateral flow immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasal swab specimens from individuals suspected of COVID-19. The test is designed for use with self-collected samples within the first 7 days post-onset of symptoms, as an aid in identifying SARS-CoV-2
Overview. Timely and accurate diagnostic testing for SARS-CoV-2 is an essential part of a comprehensive COVID-19 response strategy. Ag-RDTs can be performed by individuals in which they collect their own specimen, perform a simple rapid test and interpret their test result themselves at a time and place of their choosing, termed COVID-19 self
In both kinds of tests, a positive result means an active COVID-19 infection has been detected; a negative test result means an active COVID-19 infection has not been detected. iHealthNOW COVID-19
You are being given this Fact Sheet because your sample(s) was tested for the Coronavirus Disease 2019 (COVID-19) using the LumiraDx SARS-CoV-2 Ag Test. This Fact Sheet contains information to help you understand the risks and benefits of using this test for the diagnosis of COVID-19. After reading this Fact Sheet, if you have questions or
Evaluated RAT demonstrated satisfactory performance with more reliable results in younger patients. Humasis COVID-19 Ag RAT is potentially a valuable tool in areas where access to molecular methods is limited; however, RT-PCR remains a gold standard for SARS-CoV-2 detection.
Step 2: Run the Test. 1. Hold the top of the test firmly with. 2. The swab should be flat in the test one hand and place the swab tip (soft and cover the sample port. end) into the sample port
Lateral flow immunoassay. Sensitivity. 84.6%. Disposable. Yes. Includes. 40 cardboard, book-shaped hinged test cards with test strips, 1 x 7.5 mL extraction reagent bottle with reagent, 40 sterile nasal swabs, 1 positive control swab containing non-infectious recombinant SARS-CoV-2 nucleocapsid antigen, 1 negative control swab, 1 product insert
Humasis COVID-19 Ag Test: 12/23/2022 individuals without symptoms or other epidemiological reasons to suspect COVID-19), the test is now authorized for use at least three times over five days
The Point of Care (POC) Celltrion DiaTrust COVID-19 Ag Rapid Test is intended to detect the presence of SARS-CoV-2, the virus that causes COVID-19, based on a nasopharyngeal (deep inside the nose
Humasis COVID-19 Ag Test uses monoclonal antibodies specific to COVID-19 antigens to detect COVID-19 specific antigens in human nasal swab and nasopharyngeal swab specimens. The test shows the same sensitivity and specificity for OMICRON and other virus variants.
